Your browser doesn't support javascript.
loading
A Perspective on Synthetic Biology in Drug Discovery and Development-Current Impact and Future Opportunities.
David, Florian; Davis, Andrew M; Gossing, Michael; Hayes, Martin A; Romero, Elvira; Scott, Louis H; Wigglesworth, Mark J.
Afiliação
  • David F; Department of Biology and Biological Engineering, Division of Systems and Synthetic Biology, Chalmers University of Technology, Gothenburg, Sweden.
  • Davis AM; Discovery Sciences, Biopharmaceutical R&D, AstraZeneca, Cambridge, UK.
  • Gossing M; Discovery Sciences, Biopharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
  • Hayes MA; Discovery Sciences, Biopharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
  • Romero E; Discovery Sciences, Biopharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
  • Scott LH; Discovery Sciences, Biopharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
  • Wigglesworth MJ; Discovery Sciences, Biopharmaceuticals R&D, AstraZeneca, Alderley Park, UK.
SLAS Discov ; 26(5): 581-603, 2021 06.
Article em En | MEDLINE | ID: mdl-33834873
The global impact of synthetic biology has been accelerating, because of the plummeting cost of DNA synthesis, advances in genetic engineering, growing understanding of genome organization, and explosion in data science. However, much of the discipline's application in the pharmaceutical industry remains enigmatic. In this review, we highlight recent examples of the impact of synthetic biology on target validation, assay development, hit finding, lead optimization, and chemical synthesis, through to the development of cellular therapeutics. We also highlight the availability of tools and technologies driving the discipline. Synthetic biology is certainly impacting all stages of drug discovery and development, and the recognition of the discipline's contribution can further enhance the opportunities for the drug discovery and development value chain.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Descoberta de Drogas / Biologia Sintética / Desenvolvimento de Medicamentos Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: SLAS Discov Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Suécia

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Descoberta de Drogas / Biologia Sintética / Desenvolvimento de Medicamentos Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: SLAS Discov Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Suécia